超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

美國Dynavax Technologies 
流感疫苗 Dynavax技術公司是一家臨床階段的生物制藥公司，致力于發現和開發新產品，以預防和治療感染性疾病。

Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious diseases. Our clinical-stage product candidates include:

Phase 3 HEPLISAV ? Hepatitis B Vaccine
Phase 1 Hepatitis C Therapy
Phase 1 Hepatitis B Therapy
In addition, we are developing a preclinical Universal Flu vaccine and programs partnered with pharmaceutical companies, including AstraZeneca and GlaxoSmithKline.

Our European subsidiary Rhein Biotech manufactures hepatitis B surface antigen for HEPLISAV. With 20 years in business, Rhein Biotech also provides integrated product development services to enable its partners to bring products to market.